MiNK Therapeutics, Inc. Conversion of Stock, Shares Issued
MiNK Therapeutics, Inc. (INKT) reported Conversion of Stock, Shares Issued of 5.45 million shares for the 1-month period ending 2021-10-31, per its 10-K filed 2023-03-24.
Discontinued › Cash Flow
us-gaap:ConversionOfStockSharesIssued1 · last filed 2023-03-24
- 2021-10-31: Conversion of Stock, Shares Issued 1 month 5.45M shares.
| Period end | Conversion of Stock, Shares Issued 1 month |
|---|---|
| 2021-10-31 | 5.45M shares 10-K · filed 2023-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |